Acute renal failure in a patient with renal carcinoma treated with Temsirolimus
Fracaso renal agudo en un paciente con carcinoma renal tratado con Temsirolimus
Read
5967
Timeswas read the article
1777
Total PDF
4190
Total HTML
Share statistics
array:21 [ "pii" => "X2013251409033618" "issn" => "20132514" "doi" => "10.3265/Nefrologia.2009.29.6.5463.en.full" "estado" => "S300" "fechaPublicacion" => "2009-12-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2009;29:612" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3304 "formatos" => array:3 [ "EPUB" => 261 "HTML" => 2564 "PDF" => 479 ] ] "Traduccion" => array:1 [ "es" => array:17 [ "pii" => "X0211699509033610" "issn" => "02116995" "doi" => "10.3265/Nefrologia.2009.29.6.5463.en.full" "estado" => "S300" "fechaPublicacion" => "2009-12-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia. 2009;29:612" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4816 "formatos" => array:3 [ "EPUB" => 230 "HTML" => 4158 "PDF" => 428 ] ] "es" => array:9 [ "idiomaDefecto" => true "titulo" => "Fracaso renal agudo en un paciente con carcinoma renal tratado con Temsirolimus" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "612" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Acute renal failure in a patient with renal carcinoma treated with Temsirolimus" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Manuel Heras Benito, M.J. Fernández-Reyes, A. Rodríguez, A. Molina, F. Álvarez-Ude, B. Esteban" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Manuel" "apellidos" => "Heras Benito" ] 1 => array:2 [ "Iniciales" => "M.J." "apellidos" => "Fernández-Reyes" ] 2 => array:2 [ "Iniciales" => "A." "apellidos" => "Rodríguez" ] 3 => array:2 [ "Iniciales" => "A." "apellidos" => "Molina" ] 4 => array:2 [ "Iniciales" => "F." "apellidos" => "Álvarez-Ude" ] 5 => array:2 [ "Iniciales" => "B." "apellidos" => "Esteban" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "X2013251409033618" "doi" => "10.3265/Nefrologia.2009.29.6.5463.en.full" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409033618?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509033610?idApp=UINPBA000064" "url" => "/02116995/0000002900000006/v0_201502091341/X0211699509033610/v0_201502091342/es/main.assets" ] ] "itemSiguiente" => array:17 [ "pii" => "X201325140903360X" "issn" => "20132514" "doi" => "10.3265/Nefrologia.2009.29.6.5458.en.full" "estado" => "S300" "fechaPublicacion" => "2009-12-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2009;29:613" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 3570 "formatos" => array:3 [ "EPUB" => 284 "HTML" => 2758 "PDF" => 528 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Hyperamylasaemia and bronchoaspiration associated with Lanthanum carbonate" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "613" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Hiperamilasemia y broncoaspiración asociadas a Carbonato de Lantano" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig1" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "45718078_f1_p613.jpg" "Alto" => 318 "Ancho" => 258 "Tamanyo" => 15112 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rosa Ramos Sánchez, M.A. Azancot, J. Bartolomé" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Rosa" "apellidos" => "Ramos Sánchez" ] 1 => array:2 [ "Iniciales" => "M.A." "apellidos" => "Azancot" ] 2 => array:2 [ "Iniciales" => "J." "apellidos" => "Bartolomé" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699509033602" "doi" => "10.3265/Nefrologia.2009.29.6.5458.en.full" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509033602?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X201325140903360X?idApp=UINPBA000064" "url" => "/20132514/0000002900000006/v0_201502091611/X201325140903360X/v0_201502091612/en/main.assets" ] "itemAnterior" => array:17 [ "pii" => "X2013251409033626" "issn" => "20132514" "doi" => "10.3265/Nefrologia.2009.29.6.5492.en.full" "estado" => "S300" "fechaPublicacion" => "2009-12-01" "documento" => "article" "licencia" => "http://www.elsevier.com/open-access/userlicense/1.0/" "subdocumento" => "fla" "cita" => "Nefrologia (English Version). 2009;29:610-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4328 "formatos" => array:3 [ "EPUB" => 253 "HTML" => 3535 "PDF" => 540 ] ] "en" => array:9 [ "idiomaDefecto" => true "titulo" => "Acute renal failure associated with Pemetrexed (Alimta®)" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "610" "paginaFinal" => "611" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Fracaso renal agudo asociado a Pemetrexed (Alimta®)" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José María Peña Porta, C. Vicente de Vera Floristán, P. Bueso Inglán, J. Florián Jericó" "autores" => array:4 [ 0 => array:2 [ "nombre" => "José María" "apellidos" => "Peña Porta" ] 1 => array:2 [ "Iniciales" => "C." "apellidos" => "Vicente de Vera Floristán" ] 2 => array:2 [ "Iniciales" => "P." "apellidos" => "Bueso Inglán" ] 3 => array:2 [ "Iniciales" => "J." "apellidos" => "Florián Jericó" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "X0211699509033629" "doi" => "10.3265/Nefrologia.2009.29.6.5492.en.full" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X0211699509033629?idApp=UINPBA000064" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409033626?idApp=UINPBA000064" "url" => "/20132514/0000002900000006/v0_201502091611/X2013251409033626/v0_201502091612/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "titulo" => "Acute renal failure in a patient with renal carcinoma treated with Temsirolimus" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "612" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "Manuel Heras Benito, M.J. Fernández-Reyes, A. Rodríguez, A. Molina, F. Álvarez-Ude, B. Esteban" "autores" => array:6 [ 0 => array:4 [ "nombre" => "Manuel" "apellidos" => "Heras Benito" "email" => array:1 [ 0 => "mheras@hgse.sacyl.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 1 => array:3 [ "Iniciales" => "M.J." "apellidos" => "Fernández-Reyes" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 2 => array:3 [ "Iniciales" => "A." "apellidos" => "Rodríguez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 3 => array:3 [ "Iniciales" => "A." "apellidos" => "Molina" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 4 => array:3 [ "Iniciales" => "F." "apellidos" => "Álvarez-Ude" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] ] ] 5 => array:3 [ "Iniciales" => "B." "apellidos" => "Esteban" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Nefrología, Hospital General de Segovia, Segovia, España, " "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "affa" ] 1 => array:3 [ "entidad" => "Servicio de Oncología Médica, Hospital General de Segovia, Segovia, España, " "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "affb" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Fracaso renal agudo en un paciente con carcinoma renal tratado con Temsirolimus" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "45618078_t1_p612.jpg" "Alto" => 86 "Ancho" => 826 "Tamanyo" => 16835 ] ] "descripcion" => array:1 [ "en" => "Progress of the renal function before and after treatment with Temsirolimus" ] ] ] "textoCompleto" => "<p class="elsevierStylePara">Dear Editor,</p><p class="elsevierStylePara">Temsirolimus, a new inhibitor of the mammalian target of rapamycin (mTOR), has shown to prolong the survival rate of patients with advanced renal carcinoma.<span class="elsevierStyleSup">1</span>We report the case of a man who suffered from acute renal failure (ARF) during his treatment with this drug.</p><p class="elsevierStylePara">A 63-year-old male with important medical history of ischaemic heart disease, type 2 diabetes mellitus initially treated with gliclazide and hypertension treated with Carvedilol and Enalapril. In June 2008, he was diagnosed with left renal carcinoma with pulmonary metastasis, for which it was decided to carry out a left nephrectomy and chemotherapy. He was initially treated with Sunitinib from August to October 2008; afterwards, from November 2008 to March 2009, he received Sorafenib. Since May 2009, due to the progression of his illness, he began treatment with Temsirolimus at a dose of 25mg IV/week. The analytical progress of the pre-treatment and that following the administration of Temsirolimus is shown in Table 1.</p><p class="elsevierStylePara">Before his scheduled visit to receive the sixth dose of Temsirolimus, the patient mentioned fatigue, a decrease in the ingestion of liquids and solids (due to ulcers in the oral mucosa) and a drop in urine volume. He did not mention any other symptoms.</p><p class="elsevierStylePara">During the physical examination, the patient was in good general state, was conscious and had clarity of mind, had no temperature, his blood pressure was 90/50mmHg and had two ulcers in the oral mucosa. There were no other pathological findings in the rest of the examination.</p><p class="elsevierStylePara">The renal Doppler ultrasound showed a normal right kidney, with good vascularisation.</p><p class="elsevierStylePara">In detail, Creatinine of 6.5mg/dl, Sodium of 133mEq/l, Potassium of 5.1mEq/l, Uric acid of 11mg/dl, Calcium of 10.7mg/dl and Haemoglobin of 13.4g/dl were found in the blood, while the rest of the complete blood count and coagulation were within normal values. Urine analysis: Creatinine of 192mg/dl and Sodium of 69mEq/l. Protein quantification in the 24-hour urine was negative.</p><p class="elsevierStylePara">In the first 24 hours following admission, the renal function continued to change with a creatinine of 7.6mg/dl, despite adequate hydratation with a saline solution, later improving without needing renal substitutive treatment and with creatinine levels of 2.2mg/dl at discharge.</p><p class="elsevierStylePara">The treatment of advanced renal carcinoma with Temsirolimus was well-tolerated, and the majority of the side effects reported were medically controlled.<span class="elsevierStyleSup">2</span> Gerullis et al analysed the tolerance to Temsirolimus in 32 patients with advanced renal carcinoma, with a slight increase in creatinine present in 40.6% of them, without leading to ARF or the need for renal replacement therapy.<span class="elsevierStyleSup">3</span> From the start of the treatment, we also noticed in our patient a slight increase in the levels of plasma creatinine, contributing to the lack of ingestion of solids and liquids. This was linked with the consumption of angiotensin-converting enzyme inhibitors, to which the patient presented a reversible ARF. Although ARF is not described as a frequent side effect of Temsirolimus, its nephrotoxic potential could be when considering this slight increase in creatinine, which aggravated renal damage through other functional factors (volume depletion, NSAIDs, etc.), as in the case of our patient. Given the fact that the primary purpose of this drug is to treat advanced renal carcinoma, when treating patients who have undergone nephrectomy, thus with a greater susceptibility to renal deterioration, the possible nephrotoxicity of Temsirolimus is of a particular interest in these patients. It is advisable therefore to monitor their renal function. <br></br></p><p class="elsevierStylePara"><a href="grande/45618078_t1_p612.jpg" class="elsevierStyleCrossRefs"><img src="45618078_t1_p612.jpg" alt="Progress of the renal function before and after treatment with Temsirolimus"></img></a></p><p class="elsevierStylePara">Table 1. Progress of the renal function before and after treatment with Temsirolimus</p>" "pdfFichero" => "P-E-S-A456-EN.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "fig1" "etiqueta" => "Tab. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "copyright" => "Elsevier España" "figura" => array:1 [ 0 => array:4 [ "imagen" => "45618078_t1_p612.jpg" "Alto" => 86 "Ancho" => 826 "Tamanyo" => 16835 ] ] "descripcion" => array:1 [ "en" => "Progress of the renal function before and after treatment with Temsirolimus" ] ] ] "bibliografia" => array:2 [ "titulo" => "Bibliography" "seccion" => array:1 [ 0 => array:1 [ "bibliografiaReferencia" => array:3 [ 0 => array:3 [ "identificador" => "bib1" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Bellmunt J, Szczylik C, Feingold J, Strahs A, Berkenblit A.Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features. Ann Oncol 2008;19:1387-92. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18385198" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 1 => array:3 [ "identificador" => "bib2" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Malizzia LJ, Hsu A. Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal carcinoma. Clin J Oncol Nurs 2008;12:639-46. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18676330" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] 2 => array:3 [ "identificador" => "bib3" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:3 [ "referenciaCompleta" => "Gerullis H, Bergmann L, Maute L, Eimer C, Otto T. Experiences and practical conclusions concerning Temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany. Cancer Chemother Pharmacol 2009;63:1097-102. <a href="http://www.ncbi.nlm.nih.gov/pubmed/18818922" target="_blank">[Pubmed]</a>" "contribucion" => array:1 [ 0 => null ] "host" => array:1 [ 0 => null ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/20132514/0000002900000006/v0_201502091611/X2013251409033618/v0_201502091612/en/main.assets" "Apartado" => array:4 [ "identificador" => "35436" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Letters to the Editor" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/20132514/0000002900000006/v0_201502091611/X2013251409033618/v0_201502091612/en/P-E-S-A456-EN.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/X2013251409033618?idApp=UINPBA000064" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 5 | 8 | 13 |
| 2024 October | 45 | 28 | 73 |
| 2024 September | 38 | 15 | 53 |
| 2024 August | 50 | 58 | 108 |
| 2024 July | 35 | 26 | 61 |
| 2024 June | 43 | 35 | 78 |
| 2024 May | 57 | 29 | 86 |
| 2024 April | 50 | 33 | 83 |
| 2024 March | 26 | 23 | 49 |
| 2024 February | 35 | 34 | 69 |
| 2024 January | 34 | 22 | 56 |
| 2023 December | 16 | 23 | 39 |
| 2023 November | 40 | 26 | 66 |
| 2023 October | 27 | 26 | 53 |
| 2023 September | 26 | 23 | 49 |
| 2023 August | 33 | 30 | 63 |
| 2023 July | 32 | 20 | 52 |
| 2023 June | 38 | 17 | 55 |
| 2023 May | 31 | 26 | 57 |
| 2023 April | 13 | 16 | 29 |
| 2023 March | 30 | 20 | 50 |
| 2023 February | 20 | 17 | 37 |
| 2023 January | 27 | 21 | 48 |
| 2022 December | 28 | 25 | 53 |
| 2022 November | 27 | 25 | 52 |
| 2022 October | 30 | 28 | 58 |
| 2022 September | 27 | 32 | 59 |
| 2022 August | 33 | 46 | 79 |
| 2022 July | 21 | 40 | 61 |
| 2022 June | 28 | 23 | 51 |
| 2022 May | 27 | 32 | 59 |
| 2022 April | 24 | 34 | 58 |
| 2022 March | 27 | 31 | 58 |
| 2022 February | 31 | 33 | 64 |
| 2022 January | 21 | 23 | 44 |
| 2021 December | 24 | 29 | 53 |
| 2021 November | 38 | 28 | 66 |
| 2021 October | 19 | 34 | 53 |
| 2021 September | 23 | 24 | 47 |
| 2021 August | 31 | 28 | 59 |
| 2021 July | 27 | 27 | 54 |
| 2021 June | 14 | 15 | 29 |
| 2021 May | 24 | 17 | 41 |
| 2021 April | 42 | 37 | 79 |
| 2021 March | 28 | 10 | 38 |
| 2021 February | 31 | 11 | 42 |
| 2021 January | 20 | 8 | 28 |
| 2020 December | 22 | 13 | 35 |
| 2020 November | 24 | 9 | 33 |
| 2020 October | 10 | 6 | 16 |
| 2020 September | 21 | 2 | 23 |
| 2020 August | 28 | 7 | 35 |
| 2020 July | 23 | 7 | 30 |
| 2020 June | 18 | 4 | 22 |
| 2020 May | 17 | 9 | 26 |
| 2020 April | 24 | 9 | 33 |
| 2020 March | 24 | 8 | 32 |
| 2020 February | 37 | 17 | 54 |
| 2020 January | 37 | 18 | 55 |
| 2019 December | 28 | 17 | 45 |
| 2019 November | 14 | 12 | 26 |
| 2019 October | 12 | 11 | 23 |
| 2019 September | 24 | 21 | 45 |
| 2019 August | 11 | 3 | 14 |
| 2019 July | 17 | 17 | 34 |
| 2019 June | 16 | 14 | 30 |
| 2019 May | 17 | 9 | 26 |
| 2019 April | 57 | 20 | 77 |
| 2019 March | 19 | 23 | 42 |
| 2019 February | 15 | 10 | 25 |
| 2019 January | 18 | 13 | 31 |
| 2018 December | 49 | 29 | 78 |
| 2018 November | 84 | 15 | 99 |
| 2018 October | 76 | 12 | 88 |
| 2018 September | 73 | 12 | 85 |
| 2018 August | 47 | 22 | 69 |
| 2018 July | 50 | 14 | 64 |
| 2018 June | 44 | 12 | 56 |
| 2018 May | 49 | 17 | 66 |
| 2018 April | 46 | 3 | 49 |
| 2018 March | 45 | 11 | 56 |
| 2018 February | 38 | 8 | 46 |
| 2018 January | 33 | 5 | 38 |
| 2017 December | 39 | 12 | 51 |
| 2017 November | 27 | 5 | 32 |
| 2017 October | 25 | 6 | 31 |
| 2017 September | 22 | 11 | 33 |
| 2017 August | 24 | 6 | 30 |
| 2017 July | 24 | 10 | 34 |
| 2017 June | 27 | 4 | 31 |
| 2017 May | 21 | 6 | 27 |
| 2017 April | 14 | 15 | 29 |
| 2017 March | 12 | 10 | 22 |
| 2017 February | 18 | 7 | 25 |
| 2017 January | 11 | 4 | 15 |
| 2016 December | 36 | 6 | 42 |
| 2016 November | 52 | 7 | 59 |
| 2016 October | 55 | 7 | 62 |
| 2016 September | 74 | 2 | 76 |
| 2016 August | 132 | 4 | 136 |
| 2016 July | 104 | 0 | 104 |
| 2016 June | 83 | 0 | 83 |
| 2016 May | 92 | 0 | 92 |
| 2016 April | 76 | 0 | 76 |
| 2016 March | 65 | 0 | 65 |
| 2016 February | 69 | 0 | 69 |
| 2016 January | 87 | 0 | 87 |
| 2015 December | 98 | 0 | 98 |
| 2015 November | 72 | 0 | 72 |
| 2015 October | 51 | 0 | 51 |
| 2015 September | 54 | 0 | 54 |
| 2015 August | 44 | 0 | 44 |
| 2015 July | 46 | 0 | 46 |
| 2015 June | 30 | 0 | 30 |
| 2015 May | 38 | 0 | 38 |
| 2015 April | 5 | 0 | 5 |
Show all
